Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
7,24 AUD | +0,28% | +3,87% | +17,72% |
Omzet 2024 * | 384 mln. 250 mln. 232 mln. | Omzet 2025 * | 429 mln. 279 mln. 259 mln. | Marktkapitalisatie | 588 mln. 382 mln. 355 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -83 mln. -54 mln. -50,11 mln. | Nettowinst (verlies) 2025 * | -2 mln. -1,3 mln. -1,21 mln. | EV/omzet 2024 * | 1,34 x |
Nettoliquiditeiten 2024 * | 72,1 mln. 46,91 mln. 43,52 mln. | Nettoliquiditeiten 2025 * | 60,91 mln. 39,63 mln. 36,77 mln. | EV/omzet 2025 * | 1,23 x |
K/w-verhouding 2024 * |
-7,08
x | K/w-verhouding 2025 * |
-211
x | Werknemers | 967 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 70,67% |
Recentste transcriptie over Mayne Pharma Group Limited
1 dag | +0,28% | ||
1 week | +3,87% | ||
Lopende maand | +6,47% | ||
1 maand | +9,70% | ||
3 maanden | +15,47% | ||
6 maanden | +118,73% | ||
Lopend jaar | +17,72% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Shawn O'Brien
CEO | Chief Executive Officer | - | 01-10-22 |
Aaron Gray
DFI | Director of Finance/CFO | - | 29-08-22 |
Keith Moore
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-15 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Frank Condella
CHM | Chairman | 70 | 30-05-18 |
Patrick Blake
BRD | Director/Board Member | 59 | 28-06-18 |
Shawn O'Brien
CEO | Chief Executive Officer | - | 01-10-22 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
28-03-24 | 7,24 | +0,28% | 147 582 |
27-03-24 | 7,22 | +5,40% | 205 009 |
26-03-24 | 6,85 | +0,29% | 158 672 |
25-03-24 | 6,83 | -1,87% | 169 350 |
22-03-24 | 6,96 | -0,14% | 109 982 |
uitgestelde koers Australian S.E., 28 maart 2024 om 06:10 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+17,72% | 383 mln. | |
+28,67% | 46,63 mld. | |
+19,30% | 22,49 mld. | |
+20,11% | 14,49 mld. | |
+0,55% | 12,98 mld. | |
+46,16% | 12,16 mld. | |
-2,44% | 7,69 mld. | |
-0,05% | 6,79 mld. | |
-8,87% | 5,73 mld. | |
+7,80% | 5,15 mld. |